New Study: Medicare Could Save Seniors Billions by Fixing Part D Incentives
A new study reveals how PBMs and Part D plans increase drug costs for seniors through misaligned incentives and fees, while outlining a path to save patients billions.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
A new study reveals how PBMs and Part D plans increase drug costs for seniors through misaligned incentives and fees, while outlining a path to save patients billions.
APCI backs the DOJ’s move to block UnitedHealth’s acquisition of Change Healthcare, citing risks to competition, patient choice, and prescription drug pricing.
After an FTC deadlock stalls a probe into PBM practices, APCI vows to keep pushing for transparency and accountability in prescription drug pricing.
APCI warns Congress is missing a key chance to curb PBM spread pricing and reform Medicaid managed care, leaving taxpayers, patients, and community pharmacies to bear the cost.